Biblio Discovery — Demo Discovery Service

80 hasil untuk "Bodei, Lisa"

Menampilkan 1–20 · 0,26 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on (68)Ga-DOTATATE PET/CT

    Ulaner, Gary A.; Bodei, Lisa

    Clin Nucl Med · 2019 · Inggris · PubMed Central

    (68)Ga-DOTATATE is a radiolabeled somatostatin analog used for the detection and characterization of somatostatin receptor (SSR)–overexpressing tumors, particularly well-differentiated neuroendocrine tumors. We present a case of a 65-year-old man with well-differentiated pancreatic neuroendocrine…

  2. Artikel Jurnal Teks lengkap

    The Role of Theranostics in Prostate Cancer

    O’Dwyer, Elisabeth; Bodei, Lisa; Morris, Michael J.

    Semin Radiat Oncol · 2021 · Inggris · PubMed Central

    Theranostics in men with metastatic castration-resistant prostate cancer (mCRPC) has been developed to target bone and the tumor itself. Currently, bone-directed targeted alpha therapy with radium-223 ((223)Ra) is the only theranostic agent proven to prolong survival in men with mCRPC who have…

  3. Artikel Jurnal Teks lengkap

    Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics

    Rahbar, Kambiz; Bodei, Lisa; Morris, Michael J.

    J Nucl Med · 2019 · Inggris · PubMed Central

    Prostate-specific membrane antigen (PSMA) is of considerable interest as a target for diagnostics and therapy of prostate cancer patients. PSMA-targeted imaging has demonstrable value in guiding the management of the clinical evolution of prostatic cancer. The use of PSMA-targeted therapy using…

  4. Artikel Jurnal Teks lengkap

    Integrating Early Rapid Post-Peptide Receptor Radionuclide Therapy Quality Assurance Scan into the Outpatient Setting

    Mahajan, Sonia; O’Donoghue, Joseph; Weber, Wolfgang dkk.

    J Nucl Med Radiat Ther · 2019 · Inggris · PubMed Central

    OBJECTIVE: To understand value of early rapid, quality-assurance (QA), post-therapy whole-body scan (Tx-WBS) in patients receiving peptide receptor radionuclide therapy (PRRT) in outpatient setting. METHODS: Sixteen patients with metastatic neuroendocrine tumors received PRRT and underwent Tx-WBS…

  5. Artikel Jurnal Teks lengkap

    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes

    Boas, F. Edward; Bodei, Lisa; Sofocleous, Constantinos T.

    J Nucl Med · 2017 · Inggris · PubMed Central

    Liver metastases are a major cause of death from colorectal cancer. Intraarterial therapy options for colorectal liver metastases include chemoinfusion via a hepatic arterial pump or port, irinotecan-loaded drug-eluting beads, and radioembolization using (90)Y microspheres. Intraarterial therapy…

  6. Artikel Jurnal Teks lengkap

    Seek and Find: Current Prospective Evidence for Prostate-specific Membrane Antigen Imaging to Detect Recurrent Prostate Cancer

    Keegan, Niamh M.; Bodei, Lisa; Morris, Michael J.

    Eur Urol Focus · 2021 · Inggris · PubMed Central

    CONTEXT: Men with biochemically relapsed prostate cancer face a clinical conundrum. Depending on the detected distribution of disease, treatment goals may range from cure with focal therapy to palliative with systemic therapy to expectant observation. Retrospective studies of prostate-specific…

  7. Artikel Jurnal Teks lengkap

    Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology

    Kidd, Mark; Modlin, Irvin M.; Bodei, Lisa dkk.

    Cell Mol Gastroenterol Hepatol · 2015 · Inggris · PubMed Central

    Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), considered a heterogeneous neoplasia, exhibit ill-defined pathobiology and protean symptomatology and are ubiquitous in location. They are difficult to diagnose, challenging to manage, and outcome depends on cell type, secretory product…

  8. Artikel Jurnal Teks lengkap

    Blood transcript analysis and metastatic recurrent small bowel carcinoid management

    Modlin, Irvin M; Drozdov, Ignat; Bodei, Lisa dkk.

    BMC Cancer · 2014 · Inggris · PubMed Central

    BACKGROUND: Detection of neuroendocrine tumor (NET) disease progression is a key issue in determining management. Currently, assessment is by imaging (MRI/CT and Octreoscan®) and plasma Chromogranin A (CgA) measurement. CASE PRESENTATION: We report use of a NET-specific multigene PCR-derived blood…

  9. Artikel Jurnal Teks lengkap

    Enchondroma of tibia as potential false-positive finding on (68)Ga-DOTATOC PET/CT scan.

    Mahajan, Sonia; Bodei, Lisa; Castellanos, Sandra Huicochea dkk.

    Clin Nucl Med · 2019 · Inggris · PubMed Central

    A 70-year-old man with history of carcinoid tumor of small bowel, was referred for (68)Ga-DOTATOC study to evaluate the extent of disease. PET/CT scan revealed known metastatic disease in liver, with other sites of involvement including pancreas, peritoneum and bones. In addition, moderately…

  10. Artikel Jurnal Teks lengkap

    The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors

    Bodei, Lisa; Ćwikla, Jarosław B.; Kidd, Mark dkk.

    J Thorac Dis · 2017 · Inggris · PubMed Central

    Bronchopulmonary (BP) neuroendocrine tumors (NETs) comprise a spectrum of tumors that develop from respiratory neuroendocrine cells and represent ~20% of all lung neoplasia and ~30% of all NETs. The only curative treatment is surgical resection. For well-differentiated forms (typical and atypical…

  11. Artikel Jurnal Teks lengkap

    Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management

    Roll, Wolfgang; Weckesser, Matthias; Seifert, Robert dkk.

    Eur J Nucl Med Mol Imaging · 2021 · Inggris · PubMed Central

    PURPOSE: The aim of this narrative review is to give an overview on current and emerging imaging methods and liquid biopsy for prediction and evaluation of response to PRRT. Current limitations and new perspectives, including artificial intelligence, are discussed. METHODS: A literature review of…

  12. Artikel Jurnal Teks lengkap

    Radiopharmaceutical therapy in cancer: clinical advances and challenges

    Sgouros, George; Bodei, Lisa; McDevitt, Michael R. dkk.

    Nat Rev Drug Discov · 2020 · Inggris · PubMed Central

    Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer. In RPT, radiation is systemically or locally delivered using pharmaceuticals that either bind preferentially to cancer cells or accumulate by physiological mechanisms. Almost…

  13. Artikel Jurnal Teks lengkap

    A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors

    Modlin, Irvin M; Aslanian, Harry; Bodei, Lisa dkk.

    Endocr Connect · 2014 · Inggris · PubMed Central

    A critical requirement in neuroendocrine tumor (NET) management is a blood biomarker test that is sensitive, specific and reproducible. We evaluated a PCR-based 51-transcript signature to detect tumors, compared it with chromogranin A (CgA) and examined the confounding effect of proton pump…

  14. Artikel Jurnal Teks lengkap

    Radiopharmaceuticals for Cancer Diagnosis and Therapy:

    Taunk, Neil K.; Escorcia, Freddy E.; Lewis, Jason S. dkk.

    Cancer J · 2024 · Inggris · PubMed Central

    Radiopharmaceutical therapy has emerged as a promising approach for the treatment of various cancers. The exploration of novel targets such as tumor-specific antigens, overexpressed receptors, and intracellular biomolecules using antibodies, peptides, or small molecules has expanded the scope of…

  15. Artikel Jurnal Teks lengkap

    Radiotheranostics in oncology: current challenges and emerging opportunities

    Bodei, Lisa; Herrmann, Ken; Schöder, Heiko dkk.

    Nat Rev Clin Oncol · 2022 · Inggris · PubMed Central

    Structural imaging remains an essential component of diagnosis, staging and response assessment in patients with cancer; however, as clinicians increasingly seek to noninvasively investigate tumour phenotypes and evaluate functional and molecular responses to therapy, theranostics — the combination…